GlassScriptPhysician profile
Roelson Rodriguez
NPI 1154919918
$8,520.32
in general payments reported to CMS, 2019-2025
27 companies · $3,117 in 2025
The $3,117 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $374 · 2022: $1,535 · 2023: $1,453 · 2024: $2,042 · 2025: $3,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,611.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,366.64 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $953.31 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $833.18 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $788.01 | 2022-2025 | Ofev, Jascayd |
| Mylan Specialty L.P. | $787.50 | 2021-2024 | Yupelri, Yupelri |
| Philips North America LLC | $530.18 | 2021-2023 | |
| Viatris Specialty LLC | $393.52 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $387.66 | 2022-2025 | Glassia |
| Grifols USA, LLC | $182.17 | 2021-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $158.86 | 2025 | Ohtuvayre |
| Abiomed | $155.75 | 2023-2024 | Impella |
| Pulmonx Corporation | $144.07 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Electromed, INC. | $130.34 | 2024-2025 | Smartvest |
| Insmed, INC. | $120.86 | 2022-2025 | Brinsupri, Arikayce |
| Mallinckrodt Hospital Products INC. | $117.19 | 2025 | Acthar |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $86.19 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $63.41 | 2023-2024 | Dupixent |
| Advanced Respiratory, INC | $63.26 | 2021 | |
| Abbvie INC. | $49.50 | 2023 | |
| Inogen, INC. | $41.11 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novartis Pharmaceuticals Corporation | $29.28 | 2022 | |
| Amgen INC. | $28.62 | 2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $25.38 | 2022 | |
| Merck Sharp & Dohme LLC | $23.06 | 2025 | Winrevair |
| Alexion Pharmaceuticals, INC. | $22.43 | 2022 | |
| Movair INC | $21.23 | 2025 | Luisa |
| E.R. Squibb & Sons, L.L.C. | $17.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roelson Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.